Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nevirapine Switch for HIV-Associated Fat Abnormalities
NCT00274001Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Sep 2001
- Primary completion
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of nevirapine in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Quality of Life (WHOQoL questionnaire) at 48 weeks and Change in triglycerides in plasma at 48 weeks. Started Sep 2001; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00274001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00274001.